Abstract
Research programs investigating the potential use of BNCT for brain tumors have been initiated in Europe and in the U.S. using epithermal neutron beams and either borocaptate sodium (BSH) or boronophenylalanine (BPA) as boron compounds. The BSH biodistribution and pharmacokinetics have been studied in patients with malignant gliomas in Japan1, Germany2, Switzerland3 and Austria4. Elevated boron concentrations were found in tumor tissue whereas normal brain tissue has shown no significant uptake. The BPA biodistribution and pharmacokinetics in patients with malignant glioma have been studied in the USA5 and Australia6 showing varying tumor uptakes and normal brain concentration’s equal to the blood boron levels.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
H. Hatanaka and Y. Nakagawa, Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy, Int. J. Radiat. Oncol. Biol. Phys. 28: 1061–1066, 1994.
D. Haritz, D. Gabel, and R. Huiskamp, Clinical phase-I study ofNa2B,,H1ISH (BSH) in patients with malignant glioma as a precondition for boron neutron capture therapy (BNCT). Int. J. Radiat. Oncol. Biol. Phys. 28: 1175–1181, 1994.
H. Fankhauser, G. Stragliotto, and P. Zbinden, Borocaptate sodium (BSH) pharmacokinetics in glioma patients, in: Boron Neutron Capture Therapy: Towards Clinical Trials of Glioma Treatment, Gabel, D., Moss, R., eds., Plenum Press, New York, NY, 1992, pp. 155–162.
K. Hasselsberger, H. Radner, and G. Pendi, Boron neutron capture therapy: boron distribution and pharmacokinetics of Na,B12H11SH in patients with glioblastoma, Cancer Res. 54, in press, 1994.
R. Bergland, E. Elowitz,,I.A. Coderre, D. Joel, and M. Chadha, 6th International Symposium on Neutron Capture Therapy for Cancer, Kobe, Japan, October 31- November 4, 1994 (abstract).
J.L. Mallesch, D.E. Moore, B.J. Allen, W.H. McCarthy, R. Jones, and W.A. Stening, The pharmacokinetics of p-boronophenylalanine.fructose in human patients with glioma and metastatic melanoma. Int. J. Radiat. Oncol. Biol. Phys. 28: 1183–1188, 1994.
N. Gupta, R.A. Gahbauer, T. E. Blue,and A. Wambersie, Dose description in boron neutron capture therapy. Int. J. Radiat. Oncol. Biol. Phys. 28: 1157–1166; 1994.
J.R. Fike, and G.T. Gobbet, Central nervous system radiation injury in large animal models, in: Radiation Injury to the Nervous System, P.H.Gutin, S.A. Leibel,and G.E. Sheline, eds., Raven Press, New York, NY, 1991, pp. 113–135.
P.R.Gavin, S.L. Kraft, L.R. Wendling, and D.L. Miller,Canine spontaneous brain tumors–a large animal model for BNCT. Strahlenther. Onkol. 165: 225–228, 1989.
P.R. Gavin, C.E. DeHaan, S.L. Kraft, M.P. Moore, L.R. Wendling, and R.V. Dorn III, Acute and late reactions following boron neutron capture epithermal-neutron therapy in dogs with spontaneous brain tumors, in: Progress in Neutron Capture Therapy for Cancer, B.J. Allen, and D.E. Moore, eds., Plenum Press, New York, NY, 1992, pp. 507–510.
P.R.Gavin, S.L. Kraft, C.E. DeHaan, C.D. Swartz, and M.L.Griebenow, Large animal normal tissue tolerance with boron neutron capture. Int. J. Radiat. Oncol. Biol. Phys. 28, 1099–1106, 1994.
A. Siefert, J. Casado, K.H.I. Philipp, R. Huiskamp, P.R. Gavin, E. Dühmke, and R.L. Moss, Brain effects observed in the canine healthy tissue tolerance studies for BNCT with borocaptate sodium at the epithermal neutron beam of the HFR, Petten, in: Advances in Neutron Capture Therapy, A.H. Soloway, R.F. Barth, and D.E. Carpenter, eds.,Plenum Press, New York, NY, 1993, pp. 575–578.
P.R. Gavin, R. Huiskamp, F.J.Wheeler, and M.L. Griebenow, Computer modeling the boron compound factor in normal brain tissue, in: Advances in Neutron Capture Therapy, A.H. Soloway, R.F. Barth, and D.E. Carpenter, eds.,Plenum Press, New York, NY, 1993, pp. 591–596.
G.M. Morris, J.A. Coderre, J.W. Hopewell, P.L. Micca, M.M. Nawrocky. H.B. Liu, and A. Bywaters, Response of the central nervous system to boron neutron capture irradiation: evaluation using rat spinal cord. Radiotherapy and Oncology 32: 249–255, 1994.
K.K. Fu, Influence of dose rate on normal tissue tolerance, in: Radiation Injury to the Nervous System, P.H.Gutin, S.A. Leibel,and G.E. Sheline, eds., Raven Press, New York. NY. 1991, pp. 69–87.
S. Hornsey, Experimental central nervous system injury from fast neutrons, in: Radiation Injury to the Nervous System, P.H.Gutin. S.A. Leibel,and G.E. Sheline, eds., Raven Press, New York, NY, 1991, pp. 137–148.
G.E.Laramore, Injury to the central nervous system after high LET radiation, in: Radiation Injury to the Nervous System, P.H.Gutin, S.A. Leibel,and G.E. Sheline, eds., Raven Press, New York, NY, 1991, pp. 341–360.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Huiskamp, R., Gavin, P.R., Coderre, J.A., Philipp, K.H.I., Wheeler, F.J. (1996). Brain Tolerance in Dogs to Boron Neutron Capture Therapy with Borocaptate Sodium (BSH) or Boronophenylalanine (BPA). In: Mishima, Y. (eds) Cancer Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9567-7_84
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9567-7_84
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9569-1
Online ISBN: 978-1-4757-9567-7
eBook Packages: Springer Book Archive